✦ LIBER ✦

Effects of Atorvastatin Versus Other Statins on Fasting and Postprandial C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Patients With Coronary Heart Disease Versus Control Subjects

✍ Scribed by Ernst J. Schaefer; Judith R. McNamara; Bela F. Asztalos; Timothy Tayler; Jennifer A. Daly; Joi L. Gleason; Leo J. Seman; Andrea Ferrari; Joel J. Rubenstein

Book ID: 113441866
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 95
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2005.01.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of atorvastatin on fasting and p

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects

✍ Ernst J Schaefer; Judith R McNamara; Timothy Tayler; Jennifer A Daly; Joi A Glea 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Comparisons of effects of statins (atorv

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects

✍ Ernst J Schaefer; Judith R McNamara; Timothy Tayler; Jennifer A Daly; Joi L Glea 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Effect of statins versus untreated dysli

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study

✍ Vasilios G. Athyros; Moses Elisaf; Athanasios A. Papageorgiou; Athanasios N. Sym 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Effects of Ezetimibe Added to Atorvastat

Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk

✍ Christian Constance; Ori Ben-Yehuda; Nanette K. Wenger; Franklin Zieve; Jianxin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 50 KB

The Effect of Darapladib on Plasma Lipop

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

✍ Emile R. Mohler III; Christie M. Ballantyne; Michael H. Davidson; Markolf Hanefe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Comparison of Effectiveness of Rosuvasta

Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA Study)

✍ D. John Betteridge; J. Martin Gibson; Philip T. Sager 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB